Phenotypic polymorphism of haptoglobin: A novel risk factor for the development of infection in liver cirrhosis

Human Immunology

Volumn 72, Issue 4, 2011, Pages 348-354

  Vitalis, Zsuzsanna ^a   Altorjay, Istvan ^a   Tornai, Istvan ^a   Palatka, Karoly ^a   Kacska, Sandor ^a   Palyu, Eszter ^a   Tornai, David ^a   Udvardy, Miklos ^a   Harsfalvi, Jolan ^a   Dinya, Tamas ^a   Veres, Gabor ^b   Lakatos, Peter Laszlo ^b   Papp, Maria ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Bacterial infection; Haptoglobin polymorphism; Liver cirrhosis

Indexed keywords

HAPTOGLOBIN;

ADULT; ARTICLE; BACTERIAL INFECTION; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RISK FACTOR;

AGED; ALLELES; BACTERIAL INFECTIONS; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPTOGLOBINS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 79952620387     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.01.008     Document Type: Article

References (33)

1. Borzio M., Salerno F., Piantoni L., Cazzaniga M., Angeli P., Bissoli F., et al. Bacterial infection in patients with advanced cirrhosis: A multicentre prospective study. Dig Liver Dis 2001, 33:41-48.
2. Tandon P., Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008, 28:26-42.
3. Thalheimer U., Triantos C.K., Samonakis D.N., Patch D., Burroughs A.K. Infection, coagulation, and variceal bleeding in cirrhosis. Gut 2005, 54:556-563.
4. Christou L., Pappas G., Falagas M.E. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol 2007, 102:1510-1517.
5. Yoshida H., Hamada T., Inuzuka S., Ueno T., Sata M., Tanikawa K. Bacterial infection in cirrhosis, with and without hepatocellular carcinoma. Am J Gastroenterol 1993, 88:2067-2071.
6. Caly W.R., Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993, 18:353-358.
7. Bernard B., Grangé J.D., Khac E.N., Amiot X., Opolon P., Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis. Hepatol 1999, 29:1655-1661.
8. Soares-Weiser K., Brezis M., Tur-Kaspa R., Leibovici L. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev 2002, CD002907.
9. Langlois M.R., Delanghe J.R. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996, 42:1589-1600.
10. Asleh R., Levy A.P. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease. Vasc Health Risk Manag 2005, 1:19-28.
11. Kristiansen M., Graversen J.H., Jacobsen C., Sonne O., Hoffman H.J., Law S.K., et al. Identification of the haemoglobin scavenger receptor. Nature Lond 2001, 409:198-201.
12. Arredouani M., Matthijs P., Van Hoeyveld E., Kasran A., Baumann H., Ceuppens J.L., et al. Hemoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology 2003, 108:144-151.
13. Guetta J., Strauss M., Levy N.S., Fahoum L., Levy A.P. Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free hemoglobin. Atherosclerosis 2007, 191:48-53.
14. Bowman B.H., Kurosky A. Haptoglobin: The evolutionary product of duplication, unequal crossing over, and point mutation. Adv Hum Genet 1982, 12:189-261.
15. Koch W., Latz W., Eichinger M., Roguin A., Levy A.P., Schömig A., Kastrati A. Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. Clin Chem 2002, 48:1377-1382.
16. Carter K., Worwood M. Haptoglobin: A review of the major allele frequencies worldwide and their association with diseases. Int J Lab Hematol 2007, 29:92-110.
17. Carey E., Carey W.D. Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete?. Cleve Clin J Med 2010, 8:519-527.
18. Escorsell A., Garcia-Pagán J.C., Bosch J. Assessment of portal hypertension in humans. Clin Liver Dis 2001, 3:575-589.
19. Durand F., Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 2005, 42(Suppl):S100-S107.
20. Kamath P.S., Kim W.R. The model for end-stage liver disease (MELD). Hepatol 2007, 45:797-805.
21. Yang S.E., Min W.K., Park H., Chun S., Nah J., Kim J.Q. Distribution of haptoglobin phenotypes in a Korean population, using the semi-automated PhastSystem. Ann Clin Biochem 2003, 37:205-209.
22. Tauszik T., Szabo L. Haptoglobin polymorphism in Hungary. Genes Geogr 1992, 6:153-157.
23. Wasserzug O., Blum S., Klement E., Lejbkowicz F., Miller-Lotan R., Levy A.P. Haptoglobin 1-1 genotype and the risk of life-threatening Streptococcus infection: Evolutionary implications. J Infect 2007, 54:410.
24. Bowman B.H., Kurosky A. Haptoglobin: The evolutionary product of duplication, unequal crossing over, and point mutation. Adv Hum Genet 1982, 12:189-261.
25. Couper K.N., Blount D.G., Riley E.M. IL-10: The master regulator of immunity to infection. J Immunol 2008, 180:5771-5777.
26. Langlois M., Delanghe J., Philippé J., Ouyang J., Bernard D., De Buyzere M., et al. Distribution of lymphocyte subsets in bone marrow and peripheral blood is associated with haptoglobin type. Binding of haptoglobin to the B-cell lectin CD22. Eur J Clin Chem Clin Biochem 1997, 35:199-205.
27. Saeed S.A., Ahmad N., Ahmed S. Dual inhibition of cyclooxygenase and lipoxygenase by human haptoglobin: Its polymorphism and relation to hemoglobin binding. Biochem Biophys Res Commun 2007, 353:915-920.
28. Elg S.A., Carson L.F., Fowler J.M., Twiggs L.B., Moradi M.M., Ramakrishnan S. Ascites levels of haptoglobin in patients with ovarian cancer. Cancer 1993, 71:3938-3941.
29. Huntoon K.M., Wang Y., Eppolito C.A., Barbour K.W., Berger F.G., Shrikant P.A., et al. The acute phase protein haptoglobin regulates host immunity. J Leukoc Biol 2008, 84:170-181.
30. Yang F., Friedrichs W.E., Navarijo-Ashbaugh A.L., deGraffenried L.A., Bowman B.H., Coalson J.J. Cell type-specific and inflammatory-induced expression of haptoglobin gene in lung. Lab Invest 1995, 73:433-440.
31. Harvey S., Kohga S., Sait S.N., Markus G., Hurd T.C., Martinick M., et al. Co-expression of urokinase with haptoglobin in human carcinomas. J Surg Res 2009, 152:189-197.
32. Norman K., Pirlich M. Gastrointestinal tract in liver disease: Which organ is sick?. Curr Opin Clin Nutr Metab Care 2008, 11:613-619.
33. Wiest R., Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005, 41:422-433.